ArticleACS pharmacology & translational science2023

Development of Melanocortin 4 Receptor Agonists by Exploiting Animal-Derived Macrocyclic, Disulfide-Rich Peptide Scaffolds.

Edin Muratspahić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.